Search Results
Phase II Trial in Glioblastoma with ONC201, a First in Class DRD2 Antagonist
Onc201
The Role of DRD2 in Cancer, and the Effects of DRD2 Antagonism Via ONC201
CAPTIVE Clinical Trial for Glioblastoma
ONC201's Mechanism of Action Explained: A Life Science Animation Production for Chimerix
Study Reveals ONC201 Nearly Doubles Survival Rate for DIPG/DMG Patients
ONC201 in Recurrent H3 K27M-Mutant Diffuse Midline Glioma
GC11711 ONC201 1616632-77-9
Ethical concerns in Phase II Trial
Kazia Therapeutics webinar - Combating childhood brain cancer
Dr. Minesh Mehta Speaks About Neuro-Oncology and the Opportunities Presented by ONC201
Dr. Fong Discusses a Phase II Trial of Intramoral Electroporation of Plasmid IL-12 in Melanoma
